Diane S. Goostree
Ms. Goostree has 30 years of experience in the pharmaceutical and cosmeceutical industries. She was a key executive building SkinMedica® from 2002 onward. Prior to her appointment as CEO of ALASTIN Skincare®, she was the CEO of Intrepid Therapeutics, Inc., developing new molecules for prescription dermatology products. Her background includes experience in business development, R&D, sales and marketing, manufacturing, and general management. Ms. Goostree’s career successes have included significant capital raises, obtaining FDA approval for products and medical devices, and taking a company public. Ms. Goostree holds a B.S. in Chemical Engineering from the University of Kansas and earned her MBA from the University of Missouri at Kansas City.
Alan Widgerow MBBCh (MD); MMed (MHS); FCS; FACS
Chief Medical Officer
Professor Widgerow spent 20 years in private plastic surgical practice in South Africa before relocating to southern California in 2009 to pursue his interests in research, medical device innovations, and wound care. In 2012, he joined the University of California Irvine Plastic Surgery Division as Adjunct Professor and Director of the Center for Tissue Engineering. He has developed multiple products, among them, Scar Recovery Gel (topical scar product), Burnshield Advance (tensile silicone sheet), COMFIflow™ (nasal cannula), COVERSCIENCE®(healing make-up), DERMAPPROX® (wound approximator), Flavonix® (topical antibiofilm preparation), many of which are sold in several countries for the plastic surgery and dermatology markets. Professor Widgerow continues to play an active role in academic medicine world-wide, and his exceptional scientific knowledge of wound healing, cellular, and skin aging is invaluable to the design of ALASTIN Skincare® clinical studies and new product development.
Mr. Garruto was the founding formulation scientist and former Vice President of Formulation Development at SkinMedica®, Inc. Developer of SkinMedica’s® successful TNS line, Mr. Garruto has 38 years of experience as a formulating chemist and technical consultant to the personal care industry. He has formulated thousands of products and been granted numerous patents for products in the area of skincare and personal care.
Chief Financial Officer
Mr. Christenson has over 25 years of professional level experience in finance and accounting, primarily in healthcare-related industries. Prior to joining ALASTIN Skincare®, he provided financial leadership to several local companies including Diversa Corporation, SkinMedica®, Inc., and most recently, Zogenix, Inc. His background includes debt and equity financings, pharmaceutical and cosmeceutical product launches, and business development and M&A transactions. Mr. Christenson holds a BA in Economics from the University of California, Irvine and an MBA in Finance from the University of Illinois, Urbana-Champaign.
James P. Hartman
Chief Commercial Officer
Mr. Hartman holds a proven track record of successful business leadership and development of leading brands in the medical aesthetics arena. He most recently served as Vice President & General Manager at Solta Medical, a division of Valeant Pharmaceuticals. Prior to Solta, he was at Merz Aesthetics where he was the Vice President & U.S. Head of Aesthetics & OTC. Mr. Hartman also served as Vice President, Global Marketing and Business Development at Obagi Medical, building that company into the leading physician-dispensed skin care brand during his tenure.
Vice President, Marketing
Wendy Johnson brings to Alastin Skincare over 22 years of pharmaceutical, biotechnology, and aesthetics industry experience in various sales, training, marketing and thought leader development roles. After spending 10 years in gastroenterology at Tap Pharmaceuticals and Prometheus Laboratories, with sales and marketing oversight for in-line and pre-launch products, Mrs. Johnson transitioned to an aesthetic career at SkinMedica in 2004. While there, she was responsible for marketing one of the top 2 branded prescription hydroquinones, launching a leading branded low potency steroid, and oversight of the acne franchise line extensions. In 2010, Wendy joined Merz North America where she developed and managed the Physician Relations department in support of injectable, topical and device business units under Medical Affairs, before transitioning into managing a Regional Aesthetics Marketing team.
Vice President, Commercial Operations & Strategic Planning
Mr. Ramsinghani has over 15 years of experience in the pharmaceutical, biotech, and medical device space both in consulting and industry roles. He led the commercial operations group at Kythera and built the commercial operations infrastructure from the ground up in advance of the Kybella™ launch. He also was an Associate Principal with ZS Associates and supported multiple healthcare clients to launch or improve performance of their products. During his consulting career, he supported Allergan’s aesthetics business (including injectables, SkinMedica, and plastic surgery.) Mr. Ramsinghani has an MBA with distinction from the Kellogg School of Management at Northwestern University and a Bachelor of Science in Chemical Engineering from the University of Arizona.